Nuvectra (NVTR) Receives New Coverage from Analysts at JMP Securities

Equities research analysts at JMP Securities began coverage on shares of Nuvectra (NASDAQ:NVTR) in a report released on Wednesday, Marketbeat reports. The brokerage set an “outperform” rating on the stock.

NVTR has been the subject of several other reports. Piper Jaffray Companies reissued a “hold” rating and set a $12.00 price target on shares of Nuvectra in a research report on Friday, November 3rd. ValuEngine raised shares of Nuvectra from a “strong sell” rating to a “sell” rating in a research report on Wednesday, January 31st. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $12.00.

Nuvectra (NASDAQ:NVTR) traded up $0.48 during mid-day trading on Wednesday, hitting $10.74. 95,900 shares of the company’s stock traded hands, compared to its average volume of 116,944. Nuvectra has a 1-year low of $5.76 and a 1-year high of $15.00. The company has a quick ratio of 2.72, a current ratio of 2.90 and a debt-to-equity ratio of 0.37.

Several hedge funds have recently added to or reduced their stakes in NVTR. Wells Fargo & Company MN lifted its position in shares of Nuvectra by 1.3% during the second quarter. Wells Fargo & Company MN now owns 114,492 shares of the company’s stock valued at $1,520,000 after buying an additional 1,495 shares during the last quarter. Northern Trust Corp increased its holdings in shares of Nuvectra by 1.7% during the second quarter. Northern Trust Corp now owns 169,659 shares of the company’s stock valued at $2,253,000 after acquiring an additional 2,811 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Nuvectra by 6.2% during the second quarter. Vanguard Group Inc. now owns 310,794 shares of the company’s stock valued at $4,128,000 after acquiring an additional 18,081 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Nuvectra by 3.1% during the second quarter. Dimensional Fund Advisors LP now owns 701,849 shares of the company’s stock valued at $9,321,000 after acquiring an additional 21,140 shares in the last quarter. Finally, OxFORD Asset Management LLP acquired a new position in shares of Nuvectra during the second quarter valued at about $154,000. 48.41% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “Nuvectra (NVTR) Receives New Coverage from Analysts at JMP Securities” was originally published by American Banking News and is the property of of American Banking News. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://www.americanbankingnews.com/2018/02/14/nuvectra-nvtr-coverage-initiated-at-jmp-securities.html.

About Nuvectra

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company’s Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company’s commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs.

Receive News & Ratings for Nuvectra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply